The war on cancer: Lessons from the war on terror

Frontiers in Oncology

Volumn 4, Issue OCT, 2014, Pages

  Huang, Sui ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; HUMAN; MORBIDITY; NEOPLASM; PUBLIC HEALTH; TUMOR GROWTH;

EID: 84907726572     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00293     Document Type: Article

References (37)

1. (2014). Center for Army Lessons Learned [Online]. Available: http://usacac.army.mil/CAC2/call/ [Accessed May 3 2014].
2. Andarawewa, K.L., Erickson, A.C., Chou, W.S., Costes, S.V., Gascard, P., Mott, J.D., Bissell, M.J., and Barcellos-Hoff, M.H. (2007). Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. Cancer Res 67, 8662-8670. doi: 10.1158/0008-5472.CAN-07-1294.
3. Boland, C.R., and Goel, A. (2005). Somatic evolution of cancer cells. Semin Cancer Biol 15, 436-450.
4. Brock, A., Chang, H., and Huang, S. (2009). Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours. Nat Rev Genet 10, 336-342. doi: nrg2556 [pii] 10.1038/nrg2556.
5. Chan, J.K., Roth, J., Oppenheim, J.J., Tracey, K.J., Vogl, T., Feldmann, M., Horwood, N., and Nanchahal, J. (2012). Alarmins: awaiting a clinical response. J Clin Invest 122, 2711-2719. doi: 10.1172/JCI62423.
6. Chang, H.Y., Sneddon, J.B., Alizadeh, A.A., Sood, R., West, R.B., Montgomery, K., Chi, J.T., Van De Rijn, M., Botstein, D., and Brown, P.O. (2004). Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2, E7.
7. Csermely, P., Agoston, V., and Pongor, S. (2005). The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 26, 178-182.
8. Dallas, N.A., Xia, L., Fan, F., Gray, M.J., Gaur, P., Van Buren, G., 2nd, Samuel, S., Kim, M.P., Lim, S.J., and Ellis, L.M. (2009). Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 69, 1951-1957. doi: 0008-5472.CAN-08-2023 [pii] 10.1158/0008-5472.CAN-08-2023.
9. Darwin, C.R. (1869). Origin of Species. London: London John Murray.
10. Davies, P.C., and Lineweaver, C.H. (2011). Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors. Phys Biol 8, 015001. doi: 10.1088/1478-3975/8/1/015001.
11. Dearing, K.R., Sangal, A., and Weiss, G.J. (2014). Maintaining clarity: Review of maintenance therapy in non-small cell lung cancer. World J Clin Oncol 5, 103-113. doi: 10.5306/wjco.v5.i2.103.
12. Diaz, L.A., Jr., Williams, R.T., Wu, J., Kinde, I., Hecht, J.R., Berlin, J., Allen, B., Bozic, I., Reiter, J.G., Nowak, M.A., Kinzler, K.W., Oliner, K.S., and Vogelstein, B. (2012). The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486, 537-540. doi: 10.1038/nature11219.
13. Dickinson, E. (2009). A Bright Shining Slogan. How "hearts and minds" came to be. [Online]. Available: http://www.foreignpolicy.com/articles/2009/08/13/a_bright_shining_slogan [Accessed May 3 2013].
14. Dvorak, H.F. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315, 1650-1659. doi: 10.1056/NEJM198612253152606.
15. Ghisolfi, L., Keates, A.C., Hu, X., Lee, D.K., and Li, C.J. (2012). Ionizing radiation induces stemness in cancer cells. PLoS ONE 7, e43628. doi: 10.1371/journal.pone.0043628.
16. Hanahan, D. (2014). Rethinking the war on cancer. Lancet 383, 558-563. doi: 10.1016/S0140- 6736(13)62226-6.
17. Huang, S. (2012). Tumor progression: Chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution. Prog Biophys Mol Biol 110, :69-86.
18. Iyer, R., and Lehnert, B.E. (2002). Low dose, low-LET ionizing radiation-induced radioadaptation and associated early responses in unirradiated cells. Mutat Res 503, 1-9. doi: S0027510702000684 [pii].
19. Jackson, T.R., Salmina, K., Huna, A., Inashkina, I., Jankevics, E., Riekstina, U., Kalnina, Z., Ivanov, A., Townsend, P.A., Cragg, M.S., and Erenpreisa, J. (2013). DNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cells. Cell Cycle 12, 430- 441. doi: 10.4161/cc.23285.
20. Kreso, A., O'brien, C.A., Van Galen, P., Gan, O.I., Notta, F., Brown, A.M., Ng, K., Ma, J., Wienholds, E., Dunant, C., Pollett, A., Gallinger, S., Mcpherson, J., Mullighan, C.G., Shibata, D., and Dick, J.E. (2013). Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer. Science 339, 543-548. doi: 10.1126/science.1227670.
21. Leaf, C. (2013). The Truth in Small Doses: Why We're Losing the War on Cancer-and How to Win It New York: Simon & Schuster.
22. Lee, G.Y., Shim, J.S., Cho, B., Jung, J.Y., Lee, D.S., and Oh, I.H. (2011). Stochastic acquisition of a stem celllike state and drug tolerance in leukemia cells stressed by radiation. Int J Hematol 93, 27-35. doi: 10.1007/s12185-010-0734-2.
23. Markman, M. (2011). Commentary: Implications of cancer managed as a "chronic illness". Curr Oncol Rep 13, 90-91. doi: 10.1007/s11912-010-0148-6.
24. Nietzsche, F. (1998). Twilight of the Idols Oxford: Oxford: Oxford University Press.
25. Nor, C., Zhang, Z., Warner, K.A., Bernardi, L., Visioli, F., Helman, J.I., Roesler, R., and Nor, J.E. (2014). Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. Neoplasia 16, 137-146. doi: 10.1593/neo.131744.
26. Nowak, M.A., Michor, F., and Iwasa, Y. (2006). Genetic instability and clonal expansion. J Theor Biol 241, 26-32. doi: 10.1016/j.jtbi.2005.11.012.
27. Peters, L.J., and Hewitt, H.B. (1974). Studies of the mechanism of the Revesz effect. Br J Radiol 47, 739- 740.
28. Pisco, A.O., Brock, A., Zhou, J., Moor, A., Mojtahedi, M., Jackson, D., and Huang, S. (2013). Non- Darwinian dynamics in therapy-induced cancer drug resistance. Nat Commun 4, 2467. doi: 10.1038/ncomms3467.
29. Pohlmann, P.R., Mayer, I.A., and Mernaugh, R. (2009). Resistance to Trastuzumab in Breast Cancer. Clin Cancer Res 15, 7479-7491. doi: 10.1158/1078-0432.CCR-09-0636.
30. Polyak, K. (2014). Tumor Heterogeneity Confounds and Illuminates: A case for Darwinian tumor evolution. Nat Med 20, 344-346. doi: 10.1038/nm.3518.
31. Rosenzweig, S.A. (2012). Acquired resistance to drugs targeting receptor tyrosine kinases. Biochem Pharmacol 83, 1041-1048. doi: 10.1016/j.bcp.2011.12.025.
32. Savage, C. (2013). Drone Strikes Turn Allies Into Enemies, Yemeni Says. The New York Times April 23.
33. Sawyers, C.L. (2012). The 2011 Gordon Wilson lecture: overcoming resistance to targeted cancer drugs. Trans Am Clin Climatol Assoc 123, 114-123; discussion 123-115.
34. Sun, Y., Campisi, J., Higano, C., Beer, T.M., Porter, P., Coleman, I., True, L., and Nelson, P.S. (2012). Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 18, 1359-1368. doi: 10.1038/nm.2890.
35. Vincent, M. (2012). Cancer: a de-repression of a default survival program common to all cells?: a lifehistory perspective on the nature of cancer. Bioessays 34, 72-82. doi: 10.1002/bies.201100049.
36. West-Eberhard, M.J. (2005). Developmental plasticity and the origin of species differences. Proc Natl Acad Sci U S A 102 Suppl 1, 6543-6549. doi: 10.1073/pnas.0501844102.
37. Yang, A.D., Fan, F., Camp, E.R., Van Buren, G., Liu, W., Somcio, R., Gray, M.J., Cheng, H., Hoff, P.M., and Ellis, L.M. (2006). Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12, 4147-4153. doi: 12/14/4147 [pii] 10.1158/1078- 0432.CCR-06-0038.